Operating Lease, Right-of-Use Asset in USD of Microbot Medical Inc. from Q1 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Microbot Medical Inc. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q1 2019 to Q3 2025.
  • Microbot Medical Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $897K, a 687% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Microbot Medical Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $897K +$783K +687% 30 Sep 2025 10-Q 12 Nov 2025
Q2 2025 $165K -$9K -5.17% 30 Jun 2025 10-Q 12 Aug 2025
Q1 2025 $158K -$77K -32.8% 31 Mar 2025 10-Q 14 May 2025
Q4 2024 $132K -$128K -49.2% 31 Dec 2024 10-Q 12 Nov 2025
Q3 2024 $114K -$183K -61.6% 30 Sep 2024 10-Q 13 Nov 2024
Q2 2024 $174K -$191K -52.3% 30 Jun 2024 10-Q 14 Aug 2024
Q1 2024 $235K -$196K -45.5% 31 Mar 2024 10-Q 15 May 2024
Q4 2023 $260K -$242K -48.2% 31 Dec 2023 10-K 25 Mar 2025
Q3 2023 $297K -$251K -45.8% 30 Sep 2023 10-Q 14 Nov 2023
Q2 2023 $365K -$250K -40.7% 30 Jun 2023 10-Q 14 Aug 2023
Q1 2023 $431K -$260K -37.6% 31 Mar 2023 10-Q 17 May 2023
Q4 2022 $502K -$142K -22.1% 31 Dec 2022 10-K 27 Mar 2024
Q3 2022 $548K -$137K -20% 30 Sep 2022 10-Q 14 Nov 2022
Q2 2022 $615K -$59K -8.75% 30 Jun 2022 10-Q 15 Aug 2022
Q1 2022 $691K -$34K -4.69% 31 Mar 2022 10-Q 16 May 2022
Q4 2021 $644K -$131K -16.9% 31 Dec 2021 10-K 31 Mar 2023
Q3 2021 $685K -$137K -16.7% 30 Sep 2021 10-Q 15 Nov 2021
Q2 2021 $674K -$195K -22.4% 30 Jun 2021 10-Q 16 Aug 2021
Q1 2021 $725K -$191K -20.9% 31 Mar 2021 10-Q 17 May 2021
Q4 2020 $775K -$187K -19.4% 31 Dec 2020 10-K 31 Mar 2022
Q3 2020 $822K +$401K +95.2% 30 Sep 2020 10-Q 16 Nov 2020
Q2 2020 $869K +$377K +76.6% 30 Jun 2020 10-Q 14 Aug 2020
Q1 2020 $916K +$354K +63% 31 Mar 2020 10-Q 15 May 2020
Q4 2019 $962K 31 Dec 2019 10-K 31 Mar 2021
Q3 2019 $421K 30 Sep 2019 10-Q 14 Nov 2019
Q2 2019 $492K 30 Jun 2019 10-Q 14 Aug 2019
Q1 2019 $562K 31 Mar 2019 10-Q 15 May 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.